EFFECT OF DPC 333, A HUMAN TUMOR NECROSIS FACTOR α CONVERTING ENZYME INHIBITOR, ON THE DISPOSITION OF METHOTREXATE: A TRANSPORTER BASED DRUG-DRUG INTERACTION CASE STUDY